期刊文献+

贵阳地区健康体检人群珠蛋白生成障碍性贫血的筛查及基因型分析 被引量:1

Screening and genetic diagnosis of thalassemia in health check-up population in Guiyang
下载PDF
导出
摘要 目的了解贵阳地区健康体检人群中珠蛋白生成障碍性贫血的携带率及基因突变型。方法选择在该院进行常规健康体检的人员共3 561例为研究对象,经血常规检查方法获得对珠蛋白生成障碍性贫血疑似病例后,采用Gap-PCR及反向斑点杂交(RDB)进行α-、β-珠蛋白生成障碍性贫血基因分析。结果血常规检查获得196例珠蛋白生成障碍性贫血疑似病例,进一步的基因分析共检出珠蛋白生成障碍性贫血131例,珠蛋白生成障碍性贫血携带率为3.68%(131/3 561);其中α-珠蛋白生成障碍性贫血65例,携带率为1.83%(65/3 561),以--^(SEA)/αα为主;β-珠蛋白生成障碍性贫血60例,携带率为1.68%(60/3 561),以β^(CD41-42)及β^(CD17)为主;αβ复合型珠蛋白生成障碍性贫血6例,携带率为0.17%(6/3 561)。结论贵阳地区健康体检人群珠蛋白生成障碍性贫血携带率为3.68%,基因突变类型与以往报道一致。以常规健康体检人群为调查对象,能较为真实地反映贵阳地区珠蛋白生成障碍性贫血人群携带率,将有助于该地的婚育指导及珠蛋白生成障碍性贫血防控策略的制定。 Objective To investigate carrier rate and gene mutation of thalassemia in health check-up population in Guiyang.Methods A total of 3 561 persons with a routine health check-up were selected for blood tests to obtain suspected cases of thalassemia,then Gap-PCR and RDB(reverse dot blot hybridization)were performed to analyzeα-&β-thalassemia mutations.Results 196 suspected cases of thalassemia were obtained and further genetic analysis results showed that 131 cases were thalassemia and the carrier rate was 3.68%(131 out of 3 561).Among those diagnosed thalassemia,65 cases wereα-thalassemia with a frequency of 1.83%(65 out of 3 561)and the most common found was--SEA/αα,60 cases wereβ-thalassemia with a frequency of 1.68%(60 out of 3 561)and the major mutations wereβCD41-42 andβCD17,6 cases wereαandβcompound thalassemia with a frequency of 0.17%(6 out of 3 561).Conclusion The carrier rate of thalassemia is 3.68%in health check-up population from Guiyang.The prevalence ofα-thalassemia is higher thanβ-thalassemia,and the types of gene mutation are consistent with previous reports.In addition,routine health check-up population were studied in this paper,it will not only truly reflect the carrier rate of thalassemia but also benefit for marriage and childbirth guidance and the design of a screening strategy for the control of thalassemia.
作者 曾强武 刘琼 严雪梅 王琨 张望明 聂映 ZENG Qiangwu;LIU Qiong;YAN Xuemei;WANG Kun;ZHANG Wangming;NIE Ying(Department of Clinical Laboratory the First Affiliated Hospital of Guiyang University of Chinese Medicine,Guiyang,Guizhou 550001,China;Department of Gynaecology,the First Affiliated Hospital of Guiyang University of Chinese Medicine,Guiyang,Guizhou 550001,China)
出处 《检验医学与临床》 CAS 2018年第13期1872-1874,共3页 Laboratory Medicine and Clinic
基金 贵州省科技合作计划项目(黔科合LH字[2015]7282号)
关键词 珠蛋白生成障碍性贫血 携带率 健康体检 贵州 thalassemia carrier rate health check-up population Guizhou
  • 相关文献

参考文献6

二级参考文献57

  • 1单可人,谢渊,马娇,赵艳,齐晓岚,何燕,吴昌学,李毅,官志忠,任锡麟.贵州从江侗族和江口土家族人群β-地中海贫血基因突变型的研究[J].中国地方病学杂志,2005,24(5):526-529. 被引量:16
  • 2徐湘民,廖灿,刘忠英,黄以宁,张基增,李坚,彭朝辉,邱洛琳,蔡旭恒.β地中海贫血的大人群筛查及产前诊断[J].中华医学遗传学杂志,1996,13(5):258-261. 被引量:69
  • 3张新华,周英杰,李平萍,罗瑞贵,阮丽明,王荣新,吴志奎,李敏,黄有文.广西南宁市农村育龄人群地中海贫血筛查及基因型和血液学参数分析[J].中华流行病学杂志,2006,27(9):769-772. 被引量:94
  • 4覃西,毛炜,吴洁,黄琼莲.非基因法检测地中海贫血现状[J].中国优生与遗传杂志,2007,15(3):122-124. 被引量:28
  • 5Rund D,Rachmilewitz E.Beta-thalassemia [ J].N Engl JMed,2005,353(11):1135-1146.
  • 6Xu XM,Zhou YQ,Luo GX,et al.The prevalence and spec-trum of α and β thalassaemia in Guangdong province:implica-tions for the future health burden and population screening[J].J Clin Pathol,2004,57(5):517-522.
  • 7全国血红蛋白病研究协作组.20省、市、自治区60万人血红蛋白病调査[J].中华医药杂志,1983,63:382-385.
  • 8Taher AT,Cappellini MD,Musallam KM.Recent advances and treatment challenges in patients with non-transfusion-dependent thalassemia[J].Blood Rev,2012,26(Suppl 1):S1-S2.
  • 9Lal A,Porter J,Sweeters N,et al.Combined chelation therapy with deferasirox and deferoxamine in thalassemia[J].Blood Cells Mol Dis,2013,50(2):99-104.
  • 10Cassinerio E,Orofino N,Roghi A,et al.Combination of deferasirox and deferoxamine in clinical practice:an alternative scheme of chelation in thalassemia major patients[J].Blood Cells Mol Dis,2014,53(3):164-167.

共引文献265

同被引文献7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部